NewLink Genetics Corp (NLNK)

10.71
NASDAQ : Health Care
Prev Close 10.53
Day Low/High 10.51 / 11.19
52 Wk Low/High 9.23 / 37.65
Avg Volume 311.20K
Exchange NASDAQ
Shares Outstanding 29.13M
Market Cap 306.79M
EPS -1.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Corbus Pharma Bear Thesis Is Alive and Well on Sclerosis Drug Data Skewed Positive

Corbus Pharma Bear Thesis Is Alive and Well on Sclerosis Drug Data Skewed Positive

The imbalances in patient baseline characteristics provided an assist to Corbus' resunab treatment response and undermines the credibility of the trial results, a source says.

NewLink Genetics Corporation Provides Operational Update And Reports Third Quarter 2016 Financial Results

NewLink Genetics Corporation Provides Operational Update And Reports Third Quarter 2016 Financial Results

Management to Host Conference Call Today at 8:30 a.m. ET

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of Commencement Of A Class Action Involving NewLink Genetics Corporation And A Lead Plaintiff Deadline Of July 11, 2016

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of Commencement Of A Class Action Involving NewLink Genetics Corporation And A Lead Plaintiff Deadline Of July 11, 2016

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased NewLink Genetics Corporation (NASDAQ:NLNK)...

INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving NewLink Genetics Corporation And A Lead Plaintiff Deadline Of July 11, 2016

INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving NewLink Genetics Corporation And A Lead Plaintiff Deadline Of July 11, 2016

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased NewLink Genetics Corporation (NASDAQ:NLNK)...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of NewLink Genetics Corporation Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of July 11, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of NewLink Genetics Corporation Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of July 11, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of NewLink Genetics Corporation ("NewLink") (NASDAQ: NLNK) between...

DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In NewLink Genetics Corporation To Contact The Firm

DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In NewLink Genetics Corporation To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of...

These 5 Stocks Are Poised for Breakouts

These 5 Stocks Are Poised for Breakouts

These stocks look ready to break out and trade higher from current levels.

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of NewLink Genetics Corporation Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of July 11, 2016

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of NewLink Genetics Corporation Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of July 11, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of NewLink Genetics Corporation ("NewLink") (NASDAQ:NLNK) between...

SHAREHOLDER ALERT: Lundin Law PC Announces Investigation Of NewLink Genetics Corporation And Advises Investors With Losses To Contact The Firm

SHAREHOLDER ALERT: Lundin Law PC Announces Investigation Of NewLink Genetics Corporation And Advises Investors With Losses To Contact The Firm

Lundin Law PC announces it is investigating claims against NewLink Genetics Corporation ("NewLink" or the "Company") (Nasdaq: NLNK) concerning possible violations of federal securities laws.

NewLink Genetics Presents Clinical Data For IDO Pathway Inhibitor Indoximod Combinations At American Society Of Clinical Oncology (ASCO) Annual Meeting

NewLink Genetics Presents Clinical Data For IDO Pathway Inhibitor Indoximod Combinations At American Society Of Clinical Oncology (ASCO) Annual Meeting

In Two Study Posters, Indoximod Shows Promise in Combination Therapies for Melanoma and Pancreatic Cancer